Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes

NCT05979415 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
8
Enrollment
UNKNOWN
Sponsor class

Stopped Administrative decision

Conditions

Interventions

Sponsor

Alexza Pharmaceuticals, Inc.

Collaborators